New Drugs Controller General of India likely to be announced soon

The Union Public Service Commission (UPSC) conducted interviews for the appointment of the Drugs Controller General of India (DCGI) during this week. The top contenders are Dr VG Somani, Dr Rajeev Singh Raghuvanshi and Dr Jai Prakash. According to the sources soon final name will be announced.

Earlier on November 16 last year, the tenure of Dr VG Somani as the DCGI was extended by three months for the second time. Somani had also got an extension in month of August 2022. Dr Kiran Kumar Karlapu, Deputy Secretary, Department of Health and Family Welfare issued the circular regarding the extension of DCGI for a further period of three months.

The DCGI heads the Central Drugs Standard Control Organisation (CDSCO) which is responsible for ensuring quality drug supply across the country. It also has the authority to approve new drugs and regulate clinical trials.

  • Related Posts

    • Pharma
    • April 30, 2025
    • 96 views
    Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

    New Delhi:   The union health ministry has notified the Drugs & Cosmetics (Compounding of Offences) Rules 2025 to allow minor offences to be settled by fine or penalties. His is…

    • Pharma
    • April 30, 2025
    • 97 views
    US FDA approves first cell-based gene therapy for rare genetic skin disorder

    The U.S. Food and Drug Administration approved Abeona Therapeutics’ (ABEO.O), opens new tab gene therapy for a rare skin disorder on Tuesday. The gene therapy, called Zevaskyn, is approved to…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

    Centre notifies rules for compounding of offences under Drugs & Cosmetics Act

    US FDA approves first cell-based gene therapy for rare genetic skin disorder

    US FDA approves first cell-based gene therapy for rare genetic skin disorder

    Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

    Phthalates in plastics linked to 13 per cent of heart disease deaths in 2018 globally, finds study

    Cargologic receives CEIV Pharma re-certification

    Cargologic receives CEIV Pharma re-certification